Literature DB >> 16646567

Peripheral T-cell lymphoma-unspecified (PTCL-U) presenting with hypereosinophilic syndrome and pleural effusions.

Won Choi1, Yeon Hee Park, Kwang Hyun Paik, Yoon Hwan Chang, Seung-Sook Lee, Baek-Yeol Ryoo, Sung Hyun Yang.   

Abstract

Hypereosinophilic syndrome (HES) is a clinical disorder characterized by persistent eosinophilia and systemic involvement, in which a specific causative factor for the eosinophilia cannot be verified during a certain period of time. There have been only a few reported cases of this syndrome associated with malignant lymphoma. We report a case of peripheral T-cell lymphoma-unspecified with hypereosinophilic syndrome. The patient was a 42-year-old woman with an uncontrolled fever and a sore throat. Eosinophilia was observed on the peripheral blood smear. We confirmed the diagnosis by bone marrow and liver biopsies:. A bone marrow aspiration demonstrated markedly increased eosinophils (24.8%), and a liver biopsy demonstrated infiltration by scattered eosinophils and atypical lymphoid cells, which were confirmed to be T-cell lymphoma cells. This case was a distinctive presentation of peripheral T-cell lymphoma with hypereosinophilic syndrome, probably due to a paraneoplastic condition.

Entities:  

Mesh:

Year:  2006        PMID: 16646567      PMCID: PMC3891066          DOI: 10.3904/kjim.2006.21.1.57

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  9 in total

1.  Peripheral T-cell lymphoma associated consecutively with hemophagocytic lymphohistiocytosis and hypereosinophilic syndrome.

Authors:  Antonio Gutiérrez; Carlos Solano; Antonio Ferrández; Isabel Marugán; María José Terol; Isabel Benet; Mar Tormo; María Dolores Bea; José Rodríguez
Journal:  Eur J Haematol       Date:  2003-10       Impact factor: 2.997

2.  New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

Authors:  T Berki; M Dávid; B Bóné; H Losonczy; J Vass; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  The hypereosinophilic syndromes.

Authors:  W R Hardy; R E Anderson
Journal:  Ann Intern Med       Date:  1968-06       Impact factor: 25.391

Review 4.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

5.  A case of the hypereosinophilic syndrome complicated by malignant lymphoma.

Authors:  A Sato; K Kobayashi; H Okabe; S Fukuda
Journal:  J Dermatol       Date:  1983-02       Impact factor: 4.005

6.  The idiopathic hypereosinophilic syndrome.

Authors:  M Bunc; Z Remskar; A Brucan
Journal:  Eur J Emerg Med       Date:  2001-12       Impact factor: 2.799

7.  Eosinophilia associated with adult T-cell leukemia/lymphoma.

Authors:  S J Vukelja; R B Weiss; D J Perry; D L Longo
Journal:  Cancer       Date:  1988-10-15       Impact factor: 6.860

Review 8.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

9.  Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma.

Authors:  C J Kim; S H Park; J G Chi
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

  9 in total
  3 in total

1.  Eosinophilic pleural effusion: a rare manifestation of hypereosinophilic syndrome.

Authors:  Ndubuisi C Okafor; Ayodeji A Oso; Amanke C Oranu; Steven M Wolff; John J Murray
Journal:  Case Rep Med       Date:  2010-01-12

2.  Synchronous malignant B-cell lymphoma and gastric tubular adenocarcinoma associated with paraneoplastic cutaneous vasculitis: hypereosinophilic syndrome with mixed cryoglobulinemia is an important sign of paraneoplastic syndrome.

Authors:  Kazuhisa Nozawa; Hiroshi Kaneko; Tomoyasu Itoh; Yoko Katsura; Masaaki Noguchi; Fujihiko Suzuki; Yoshinari Takasaki; Hideoki Ogawa; Kenji Takamori; Iwao Sekigawa
Journal:  Rare Tumors       Date:  2009-12-28

3.  Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report.

Authors:  Masayo Yamamoto; Katsuya Ikuta; Yasumichi Toki; Mayumi Hatayama; Motohiro Shindo; Yoshihiro Torimoto; Toshikatsu Okumura
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.